US 7431932
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
granted A61KA61K35/28A61K35/765
Quick answer
US patent 7431932 (Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/28, A61K35/765, A61K48/00, A61P